![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/12/ACT001-is-an-Orally-Active-PAI-1-Inhibitor-2021-12-16.jpg)
Glioblastoma (GBM) is the most common and most aggressive primary malignant brain tumour in adults, with a high morbidity, high…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/05/J22352-PROTAC-Like-Highly-Selective-HDAC6-Inhibitor-Enhances-Antitumor-Immunity-in-Glioblastoma-2019-05-15.jpg)
Glioblastomas (also called GBM) are malignant Grade IV tumors, where a large portion of tumor cells are reproducing and dividing at…